» Articles » PMID: 37291572

Identification of Colorectal Cancer Progression-associated Intestinal Microbiome and Predictive Signature Construction

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2023 Jun 8
PMID 37291572
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The relationship between intestinal microbiome and colorectal cancer (CRC) progression is unclear. This study aims to identify the intestinal microbiome associated with CRC progression and construct predictive labels to support the accurate assessment and treatment of CRC.

Method: The 192 patients included in the study were divided into stage I-II and stage III-IV CRC patients according to the pathological stages, and preoperative stools were collected from both groups for 16S rDNA sequencing of the intestinal microbiota. Pearson correlation and Spearman correlation coefficient analysis were used to analyze the differential intestinal microbiome and the correlation with tumor microenvironment and to predict the functional pathway. XGBoost model (XGB) and Random Forest model (RF) were used to construct the microbiome-based signature. The total RNA extraction from 17 CRC tumor simples was used for transcriptome sequencing.

Result: The Simpson index of intestinal microbiome in stage III-IV CRC were significantly lower than those in stage I-II CRC. Proteus, Parabacteroides, Alistipes and Ruminococcus etc. are significantly enriched genus in feces of CRC patients with stage III-IV. ko00514: Other types of O - glycan biosynthesis pathway is relevant with CRC progression. Alistipes indistinctus was positively correlated with mast cells, immune activators IL-6 and IL6R, and GOBP_PROTEIN_FOLDING_IN_ENDOPLASMIC_RETICULUM dominantly. The Random Forest (RF) model and eXtreme Gradient Boosting (XGBoost) model constructed with 42 CRC progression-associated differential bacteria were effective in distinguishing CRC patients between stage I-II and stage III-IV.

Conclusions: The abundance and diversity of intestinal microbiome may increase gradually with the occurrence and progression of CRC. Elevated fetal abundance of Proteus, Parabacteroides, Alistipes and Ruminococcus may contribute to CRC progression. Enhanced synthesis of O - glycans may result in CRC progression. Alistipes indistinctus may play a facilitated role in mast cell maturation by boosting IL-6 production. Alistipes indistinctus may work in the correct folding of endoplasmic reticulum proteins in CRC, reducing ER stress and prompting the survival and deterioration of CRC, which may owe to the enhanced PERK expression and activation of downstream UPR by Alistipes indistinctus. The CRC progression-associated differential intestinal microbiome identified in our study can be served as potential microbial markers for CRC staging prediction.

Citing Articles

Prognostic model for log odds of negative lymph node in locally advanced rectal cancer via interpretable machine learning.

Wang Y, Pan Z, Cai H, Li S, Huang Y, Zhuang J Sci Rep. 2025; 15(1):7924.

PMID: 40050297 PMC: 11885450. DOI: 10.1038/s41598-025-90191-0.


Synergistic Effects of Probiotics and Lifestyle Interventions on Intestinal Microbiota Composition and Clinical Outcomes in Obese Adults.

Florencio G, Xavier A, Natal A, Sadoyama L, Roder D, Menezes R Metabolites. 2025; 15(2).

PMID: 39997695 PMC: 11857521. DOI: 10.3390/metabo15020070.


Genetic background and microbiome drive susceptibility to epicutaneous sensitization and food allergy in adjuvant-free mouse model.

Hornikova T, Jelinkova A, Jiraskova Zakostelska Z, Thon T, Coufal S, Polouckova A Front Immunol. 2025; 15:1509691.

PMID: 39944558 PMC: 11814220. DOI: 10.3389/fimmu.2024.1509691.


Anti-colorectal cancer effect of total minor ginsenosides produced by lactobacilli transformation of major ginsenosides by inducing apoptosis and regulating gut microbiota.

Shen Y, Gao Y, Yang G, Zhao Z, Zhao Y, Gao L Front Pharmacol. 2025; 15():1496346.

PMID: 39845805 PMC: 11750747. DOI: 10.3389/fphar.2024.1496346.


Deciphering the role of host-gut microbiota crosstalk via diverse sources of extracellular vesicles in colorectal cancer.

Song Y, Shi M, Wang Y Mol Med. 2024; 30(1):200.

PMID: 39501131 PMC: 11536884. DOI: 10.1186/s10020-024-00976-8.


References
1.
Liu X, Cheng Y, Shao L, Ling Z . Alterations of the Predominant Fecal Microbiota and Disruption of the Gut Mucosal Barrier in Patients with Early-Stage Colorectal Cancer. Biomed Res Int. 2020; 2020:2948282. PMC: 7114766. DOI: 10.1155/2020/2948282. View

2.
Conti P, Kempuraj D, Di Gioacchino M, Boucher W, Letourneau R, Kandere K . Interleukin-6 and mast cells. Allergy Asthma Proc. 2002; 23(5):331-5. View

3.
Wang Y, Alam G, Ning Y, Visioli F, Dong Z, Nor J . The unfolded protein response induces the angiogenic switch in human tumor cells through the PERK/ATF4 pathway. Cancer Res. 2012; 72(20):5396-406. PMC: 3743425. DOI: 10.1158/0008-5472.CAN-12-0474. View

4.
Cervoni G, Cheng J, Stackhouse K, Heimburg-Molinaro J, Cummings R . O-glycan recognition and function in mice and human cancers. Biochem J. 2020; 477(8):1541-1564. DOI: 10.1042/BCJ20180103. View

5.
Xu J, Wang M, Liu Q, Lin X, Pu K, He Z . Gut microbiota mediated the toxicity of high concentration of dietary nitrite in C57BL/6 mice. Ecotoxicol Environ Saf. 2022; 231:113224. DOI: 10.1016/j.ecoenv.2022.113224. View